AI biotechs launch bioprospecting expeditions with Indigenous groups, agree to share benefits
By Ben Johnson,
Nature
| 02. 14. 2025
A London-based biotech has amassed the world’s largest ethically sourced foundational biodiversity database for training artificial intelligence (AI) by setting up partnerships with 25 countries around the world. The startup, Basecamp Research, announced in January the launch of a new computer cluster that will mine their rich biodiversity database — which contains species collected from extreme locations such as the Arctic tundra and African deserts — to develop new and unique proteins with commercial potential. In agreeing to share revenues from these proteins before conducting its explorations, Basecamp brings an unusual approach to commercial bioprospecting, an activity traditionally associated with injustices towards Indigenous cultures, biopiracy and colonial practices.
The age-old search for medicines derived from nature has entered a new era. Driven by the need to increase the number of proteins to better train machine-learning algorithms, commercial bioprospecting is undergoing a renaissance. Scientists are going into unexplored areas to sample the genomes and proteins of millions of species with the ultimate goal of finding better versions of what is already in nature.
AI-based design has so far been limited to...
Related Articles
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...